× Industry Reports Services Press Release Contact us About us

North America Digital Diabetes Management Market Size, By End-use (Hospitals, Home Settings, Diagnostic Centers & Clinics), By Product Type (Devices {Smart Glucose Meters, CGM, Insulin Pumps & Patches, Insulin Pens}, By Device Type [Wearable, Handheld], Services {Diabetes Apps, Software}), By Patient Type (Type 1, Type 2), Research Report, Country Outlook (U.S., Canada), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027
Published Date: February 2021 | Publisher: Graphical Research Report ID: GR1677 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Forecast assumptions

1.3    Data sources

1.3.1    Secondary

1.3.1.1    Paid sources

1.3.1.2    Unpaid sources

1.3.2    Primary

Chapter 2   Market Summary

2.1    North America digital diabetes management industry summary, 2016 – 2027

2.1.1    Country trends

2.1.2    Product type trends

2.1.3    Patient type trends

2.1.4    End-use trends

Chapter 3   Market Analysis

3.1    Industry segmentation

3.2    Industry outlook, 2016 – 2027 (USD Million)

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1    Growing diabetes populations base

3.3.1.2    Advent of artificial intelligence and big data in diabetes devices

3.3.1.3    Rising healthcare expenditure on diabetes

3.3.1.4    Growing awareness about technologically advanced products

3.3.1.5    Favorable reimbursement policies

3.3.1.6    Rising number of product launches

3.3.1.7    Increasing technological collaboration

3.3.2    Restraints & challenges

3.3.2.1    High cost of advanced devices

3.4    Analysis of COVID-19 impact on the industry

3.5    Porter’s analysis

3.6    Competitive review, 2020

3.7    PEST analysis

Chapter 4   North America Digital Diabetes Management Market, By Product Type

4.1    Key segment trends

4.2    Devices

4.2.1    By device

4.2.2    Market size, by region, 2016 – 2027 (USD Million)

4.2.2.1    Smart glucose Meters

4.2.2.1.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.2.2    Smart CGM

4.2.2.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.2.3    Smart insulin pumps & Patches

4.2.2.3.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.2.4    Smart insulin pens

4.2.2.4.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.3    By device type

4.2.3.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.3.1.1    Wearable

4.2.3.1.1.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.3.1.2    Handheld

4.2.3.1.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.3    Services

4.3.1    Market size, by region, 2016 – 2027 (USD Million)

4.3.2    Apps

4.3.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.3.3    Software

4.3.3.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 5   North America Digital Diabetes Management Market, By Patient Type

5.1    Key segment trends

5.2    Type 1

5.2.1    Market size, by region, 2016 – 2027 (USD Million)

5.3    Type 2

5.3.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 6   North America Digital Diabetes Management Market, By End-use

6.1    Key segment trends

6.2    Hospitals

6.2.1    Market size, by region, 2016 – 2027 (USD Million)

6.3    Home settings

6.3.1    Market size, by region, 2016 – 2027 (USD Million)

6.4    Diagnostic centers & clinics

6.4.1    Market size, by region, 2016 – 2027 (USD Million)

6.5    Others

6.5.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 7   North America Digital Diabetes Management Market, By Country

7.1    Market trends

7.2    U.S.

7.2.1    Market size, by country, 2016 – 2027 (USD Million)

7.2.2    Market size, by product type, 2016 – 2027 (USD Million)

7.2.2.1    Market size, by device, 2016 – 2027 (USD Million)

7.2.2.2    Market size, by device type, 2016 – 2027 (USD Million)

7.2.2.3    Market size, by services, 2016 – 2027 (USD Million)

7.2.3    Market size, by patient type, 2016-2027 (USD Million)

7.2.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.3    Canada

7.3.1    Market size, by country, 2016 – 2027 (USD Million)

7.3.2    Market size, by product type, 2016 – 2027 (USD Million)

7.3.2.1    Market size, by device, 2016 – 2027 (USD Million)

7.3.2.2    Market size, by device type, 2016 – 2027 (USD Million)

7.3.2.3    Market size, by services, 2016 – 2027 (USD Million)

7.3.3    Market size, by patient type, 2016-2027 (USD Million)

7.3.4    Market size, by end-use, 2016 – 2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2020

8.2    Medtronic Plc

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    Abbott Laboratories

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    F Hoffmann-La Roche Ltd

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Dexcom, Inc

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6.     Sensonics

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Insulet Corporation

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Tandem Diabetes Care, Inc

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Ypsomed

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    Ascensia Diabetes Care Holdings Ag

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Tidepool

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    Glooko Inc

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    Dariohealth Corporation

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis

8.14    Novo Nordisk A/S

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Product landscape

8.14.4    Strategic outlook

8.14.5    SWOT analysis

8.15    Pendiq

8.15.1    Business overview

8.15.2    Financial data

8.15.3    Product landscape

8.15.4    Strategic outlook

8.15.5    SWOT analysis

8.16    Emperra GmbH E-Health Technologies

8.16.1    Business overview

8.16.2    Financial data

8.16.3    Product landscape

8.16.4    Strategic outlook

8.16.5    SWOT analysis
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]